-
2023-505604-32-00
5
2024-01-24
Non small cell lung cancer (NSCLC)
-
2022-503055-26-00
9
2023-10-30
Unresectable recurrent or metastatic HPV16 (Human Papilloma Virus) pos
-
2022-501703-27-00
5
2023-07-05
Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma
-
2023-504595-26-00
4
2023-05-22
Non-Small Cell Lung Cancer
-
2022-501007-28-00
5
2023-04-18
Breast Neoplasms
-
2023-505277-32-00
5
2023-01-26
Diffuse Large B-Cell Lymphoma (DLBCL)
-
2023-507031-38-00
5
2023-01-09
Severe viral lung infections
-
2022-500461-28-06
5
2022-09-15
High-Risk Metastatic Hormone-Sensitive Prostate Cancer
-
2023-506838-68-00
9
2020-12-10
Renal cell carcinoma
-
2023-509628-16-00
5
2026-05-07
Small Cell Lung Cancer (SCLC)
-
2024-514874-36-01
4
2026-04-17
Refractory angina due to obstructive coronary artery disease
-
2024-520101-39-00
5
2026-04-01
TROP2 NMR-positive advanced or metastatic non-squamous non-small cell
-
2023-504957-11-00
5
2026-03-24
Metastatic castration resistant prostate cancer
-
2025-521670-34-00
5
2026-03-04
Acute coronary syndrome (ST-elevation myocardial infarction [STEMI] or
-
2024-518777-34-00
5
2026-02-11
B7-H4-Selected Advanced/Metastatic Endometrial Cancer.
-
2025-521873-15-00
9
2026-02-09
Metastatic hormone-sensitive prostate cancer
-
2025-522960-34-00
5
2026-02-09
Established cardiovascular disease
-
2025-521627-78-00
5
2026-01-28
Neoplasms, Lung
-
2025-521917-24-00
5
2026-01-21
Treatment-Naïve Recurrent/Metastatic Head and Neck Squamous Cell Carci
-
2025-523391-22-01
6
2026-01-20
Atrial fibrillation
-
2024-514500-14-00
5
2025-12-15
Participants with KRAS G12C-Mutant, Advanced or Metastatic Nonsquamous
-
2024-513586-39-00
5
2025-12-10
Prostate Cancer
-
2024-520164-33-00
5
2025-12-09
Non-Small Cell Lung Cancer
-
2024-517091-38-00
3
2025-11-25
Head and neck squamous cell carcinoma